Education
About Us
Working with TipRanks
Follow Us
Waldencast (WALD)
NASDAQ:WALD
WALD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.48 - $4.40
Previous CloseN/A
Volume13.42K
Average Volume (3M)389.35K
Market Cap
$186.54M
Enterprise Value$683.77M
Total Cash (Recent Filing)$14.80M
Total Debt (Recent Filing)$182.11M
Price to Earnings (P/E)―
Beta0.58
Next Earnings
Nov 11, 2025EPS Estimate
-0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding112,054,380
10 Day Avg. Volume581,147
30 Day Avg. Volume389,346
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap3.67
Enterprise Value/Revenue2.50
Enterprise Value/Gross Profit3.57
Enterprise Value/Ebitda1.13K
Forecast
1Y Price Target
$3.20Price Target Upside114.77% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Bulls Say, Bears Say
Bulls Say
Brand PerformanceObagi saw strong sell-through in their core channels, which is a positive indicator for the brand.
EarningsManagement noted 2Q sales were positive YOY, indicating improvement from the previous quarter.
Bears Say
ExpectationsManagement also lowered their FY25 expectations as they are now positioning 2025 as an investment year.
Financial PerformanceWALD missed expectations and posted 1Q25 revenue of $65.4mm vs. Street's $68.1mm and adj. EBITDA of $4.4mm vs. Street's $10.3mm.
Supply ChainObagi's sales were weaker than anticipated due to ongoing supply chain challenges leading to out-of-stock situations for key products.
Waldencast News
WALD FAQ
What was Waldencast’s price range in the past 12 months?
Waldencast lowest stock price was $1.48 and its highest was $4.39 in the past 12 months.
What is Waldencast’s market cap?
Waldencast’s market cap is $186.54M.
When is Waldencast’s upcoming earnings report date?
Waldencast’s upcoming earnings report date is Nov 11, 2025 which is in 68 days.
How were Waldencast’s earnings last quarter?
Waldencast released its earnings results on Aug 18, 2025. The company reported -$0.09 earnings per share for the quarter, missing the consensus estimate of -$0.075 by -$0.015.
Is Waldencast overvalued?
According to Wall Street analysts Waldencast’s price is currently Undervalued.
Does Waldencast pay dividends?
Waldencast does not currently pay dividends.
What is Waldencast’s EPS estimate?
Waldencast’s EPS estimate is -0.08.
How many shares outstanding does Waldencast have?
Waldencast has 112,054,380 shares outstanding.
What happened to Waldencast’s price movement after its last earnings report?
Waldencast reported an EPS of -$0.09 in its last earnings report, missing expectations of -$0.075. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Waldencast?
Currently, no hedge funds are holding shares in WALD
Waldencast Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.20 (114.77% Upside)
$3.20 (114.77% Upside)
Blogger Sentiment
Bullish
WALD Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 100.0 Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-52.50%
12-Months-Change
Fundamentals
Return on Equity
-6.60%
Trailing 12-Months
Asset Growth
-6.41%
Trailing 12-Months
Company Description
Waldencast
Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.
WALD Company Deck
WALD Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call indicated both progress and challenges. While Waldencast achieved strong adjusted gross profit margins and successful product launches, revenue declined overall, and supply chain disruptions impacted performance. The company remains optimistic about future growth amid macroeconomic pressures.View all WALD earnings summariesWALD Stock 12 Month Forecast
Average Price Target
$3.20
▲(114.77% Upside)
Technical Analysis
Ownership Overview
―
Insiders
0.60% Mutual Funds
16.65% Other Institutional Investors
81.42% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---